ACT Stock Overview
An investment holding company, provides healthcare administration and health risk management solutions to the healthcare sector. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
AfroCentric Investment Corporation Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R2.60 |
52 Week High | R3.50 |
52 Week Low | R2.06 |
Beta | 0.19 |
11 Month Change | -5.45% |
3 Month Change | -8.77% |
1 Year Change | -17.72% |
33 Year Change | -49.02% |
5 Year Change | -20.00% |
Change since IPO | -42.22% |
Recent News & Updates
Recent updates
AfroCentric Investment Corporation Limited's (JSE:ACT) 29% Price Boost Is Out Of Tune With Earnings
Sep 01Pinning Down AfroCentric Investment Corporation Limited's (JSE:ACT) P/E Is Difficult Right Now
May 02Here's Why We Think AfroCentric Investment Corporation Limited's (JSE:ACT) CEO Compensation Looks Fair for the time being
Nov 04AfroCentric Investment (JSE:ACT) Has Announced A Dividend Of ZAR0.17
Oct 26AfroCentric Investment (JSE:ACT) Is Due To Pay A Dividend Of ZAR0.17
Oct 12AfroCentric Investment (JSE:ACT) Will Pay A Dividend Of ZAR0.17
Sep 16AfroCentric Investment (JSE:ACT) Will Pay A Dividend Of R0.17
Oct 03AfroCentric Investment's (JSE:ACT) Dividend Will Be R0.17
Sep 16Is Now The Time To Put AfroCentric Investment (JSE:ACT) On Your Watchlist?
Sep 05I Built A List Of Growing Companies And AfroCentric Investment (JSE:ACT) Made The Cut
Jun 04How Does AfroCentric Investment Corporation Limited (JSE:ACT) Fare As A Dividend Stock?
Apr 28I Built A List Of Growing Companies And AfroCentric Investment (JSE:ACT) Made The Cut
Feb 24Why AfroCentric Investment Corporation Limited (JSE:ACT) Should Be In Your Dividend Portfolio
Jan 18AfroCentric Investment's (JSE:ACT) Shareholders Are Down 44% On Their Shares
Dec 22Here's Why I Think AfroCentric Investment (JSE:ACT) Is An Interesting Stock
Nov 25Shareholder Returns
ACT | ZA Diversified Financial | ZA Market | |
---|---|---|---|
7D | -8.8% | 0.9% | 1.7% |
1Y | -17.7% | 15.0% | 15.6% |
Return vs Industry: ACT underperformed the ZA Diversified Financial industry which returned 13% over the past year.
Return vs Market: ACT underperformed the ZA Market which returned 15.2% over the past year.
Price Volatility
ACT volatility | |
---|---|
ACT Average Weekly Movement | 12.3% |
Diversified Financial Industry Average Movement | 4.6% |
Market Average Movement | 4.5% |
10% most volatile stocks in ZA Market | 9.5% |
10% least volatile stocks in ZA Market | 2.6% |
Stable Share Price: ACT's share price has been volatile over the past 3 months compared to the ZA market.
Volatility Over Time: ACT's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of ZA stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 5,503 | Gerald Van Wyk | www.afrocentric.za.com |
AfroCentric Investment Corporation Limited, an investment holding company, provides healthcare administration and health risk management solutions to the healthcare sector. The company operates through Healthcare SA, Healthcare Retail, Healthcare Africa, and Information Technology segments. It offers HIV and other healthcare management solutions.
AfroCentric Investment Corporation Limited Fundamentals Summary
ACT fundamental statistics | |
---|---|
Market cap | R2.15b |
Earnings (TTM) | R55.38m |
Revenue (TTM) | R8.90b |
38.9x
P/E Ratio0.2x
P/S RatioIs ACT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ACT income statement (TTM) | |
---|---|
Revenue | R8.90b |
Cost of Revenue | R4.91b |
Gross Profit | R3.99b |
Other Expenses | R3.94b |
Earnings | R55.38m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.067 |
Gross Margin | 44.86% |
Net Profit Margin | 0.62% |
Debt/Equity Ratio | 18.5% |
How did ACT perform over the long term?
See historical performance and comparison